Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by johnny007on Jun 03, 2021 12:51pm
104 Views
Post# 33319535

RE:RE:RE:RE:RE:Whatever you do

RE:RE:RE:RE:RE:Whatever you do

Hi Zed. CEO has always answered my questions directly, just for the record.
And this, despite my not so elegant tone ;-)

Will SZLS turnaround? Sure, it always does.
Only the 'end of the world is neigh' tone brings down this ship, as usual.

The valuation is far too low, we all know that.
This regardless of the 'clumsy' actions of company.
Yes yes, I elaborated on this a lot - but MCAP would be this low otherwise.
Wouldn't be surprised if this is a Clarus & Friends discount haha.

Point is, despite Tripp, there will be a rising interest in the product.
Good we know, others will take care of product placement now.

Yes, it would be awesome if Tripp can listen a bit more closely to his shareholder
and his analysts (-> Clarus). But well, what can I write - he finally did.

Let this be enough and see how they fare from here.
I took my chances around this low last 24 hours.
Don't know how long this will take - we never know.

Projection:

(1) Just the usual double or tripple before falling back within this year

(2) Aristotle gains real market traction: All multiples would only insult the shorts ;-)
But yes, a $600M - $1000M MCAP is very possible in this situation.

In this sense, a good speculative position.
When Clarus comes out from hiding, all bets are off and SP recovers.

Cheers

 

<< Previous
Bullboard Posts
Next >>